The Changing Face of Localized Prostate Cancer

Speaker: Dr. Laurence Klotz
Original Date: Tuesday, March 31, 2015
 
Dr. Laurence Klotz is a Honorary Director of Prostate Cancer Canada and a world leader in the adoption of Active Surveillance as a standard option of patient care. Thanks to his leading contributions to the treatment of prostate cancer, he was recently named to the Order of Canada.
 

In this Expert Angle webinar, Dr. Laurence Klotz:

  • Reviews 'smart screening' for prostate cancer.
  • Discusses what is over diagnosis, and how can it be effectively managed.
  • Explains what is active surveillance, and what are the results.
  • Talks about where does focal therapy fit in the management of prostate cancer.

Speaker – Dr. Laurence Klotz

EA-Klotz-(1).jpgLAURENCE KLOTZ, MD, FRCS(C)
PROFESSOR, DEPARTMENT OF SURGERY
UNIVERSITY OF TORONTO
CHAIRMAN, CANADIAN UROLOGY RESEARCH CONSORTIUM
CHAIRMAN, WORLD UROLOGIC ONCOLOGY FEDERATION

Dr. Laurence Klotz is a Professor in the Department of Surgery at the University of Toronto. He received his medical training at the University of Toronto and completed his residency at the University of Toronto Gallie Program in Surgery. Dr. Klotz is the founding and current Editor-in-Chief of the Canadian Urological Association Journal and founding Editor-in-Chief of The Canadian Journal of Urology. He is also Chairman (founding and current) of the Canadian Urology Research Consortium (CURC) and the World Urologic Oncology Federation.

Dr. Klotz has also served as Chairman of the Urological Research Society, led the Scientific Board of Prostate Cancer Canada, was Chair of the Canadian Uro-Oncology Group and NCIC GU Site Group and Treasurer of the Society of Urologic Oncology. He is a member of the American Association of Genitourinary Surgeons and past President of the Canadian Urological Association. He is an honorary member of the AUA, the Chinese Urological Society, and the Chilean Urological Society. Dr. Klotz has authored 320 peer-reviewed publications, 3 books, and hundreds of lay articles and editorials. He has been a visiting professor at leading universities throughout North America, Europe, and Asia. He has been awarded several departmental postgraduate teaching awards, ‘Best Doctors in Canada’, (2007-present) and the Queen’s Jubillee Medal (2012) for ‘meritorious public service benefitting the people of Canada’.

He has had a long term translational and clinical interest in the biology of prostate cancer, including the biology of androgen deprivation, micronutrients and prostate cancer prevention, active surveillance, and focal therapy. He has led many prospective clinical trials in prostate cancer at a national and international level.


About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

 

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive